ASX - Delayed Quote AUD
Chimeric Therapeutics Limited (CHM.AX)
0.0080
+0.0030
+(60.00%)
At close: 3:53:32 PM GMT+10
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Bourk (Eliot) Divisional Officer | Other | Jun 30, 2023 | 4,230,603 |
| Chong (Leslie) Director (Non-Executive) | Other | Jul 12, 2023 | 154,900 |
| Chow (Jennifer) Chief Executive Officer | Other | Dec 14, 2023 | 18,094,527 |
| Elkins (Cynthia) Director (Non-Executive) | Other | Jul 12, 2023 | 141,368 |
| Hains (Phillip) Director (Non-Executive) | Other | Apr 30, 2025 | 12,934,724 |
| Hopper (Paul) Executive Chairman | Other | Apr 30, 2025 | 204,994,574 |
| Matcham (George) Director (Non-Executive) | Other | Jul 12, 2023 | 2,087,756 |
| Russell (Lesley) Director | Other | Jul 12, 2023 | 1,739,130 |
Related Tickers
ALA.AX Arovella Therapeutics Limited
0.0820
-4.65%
RAD.AX Radiopharm Theranostics Limited
0.0230
+4.55%
IMU.AX Imugene Limited
0.0230
0.00%
RADX Radiopharm Theranostics Limited
4.4000
+11.11%
LSB LakeShore Biopharma Co., Ltd
1.1478
-1.05%
DYAI Dyadic International, Inc.
1.0400
-1.89%
ORGS Orgenesis Inc.
1.8900
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
9.65
+0.10%
SLRX Salarius Pharmaceuticals, Inc.
0.8699
+11.23%
CNTX Context Therapeutics Inc.
0.7900
-3.66%